Search - tctmd.com

Displaying 301 - 320 of 485

Sort: Relevancy | Date

News Daily News

Sex Differences Diminish With Third-Generation TAVR Device

L.A. McKeown

January 05, 2018

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Conference News PCR London Valves 2017

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Conference News SCCT 2017

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Yael L. Maxwell

July 08, 2017

News Daily News

Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR

Alison Palkhivala

July 07, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

Presentation TVT 2017

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

Presenter: David J. Cohen, Jeffrey J. Popma

June 16, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Daily News

Anticoagulation in Pregnant Women With Mechanical Heart Valves: A Balancing Act

Caitlin E. Cox

May 31, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

Advertisement

Sex Differences Diminish With Third-Generation TAVR Device

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Anticoagulation in Pregnant Women With Mechanical Heart Valves: A Balancing Act

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content